Your browser doesn't support javascript.
loading
Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma.
Becker-Santos, Daiana D; Thu, Kelsie L; English, John C; Pikor, Larissa A; Martinez, Victor D; Zhang, May; Vucic, Emily A; Luk, Margaret Ty; Carraro, Anita; Korbelik, Jagoda; Piga, Daniela; Lhomme, Nicolas M; Tsay, Mike J; Yee, John; MacAulay, Calum E; Lam, Stephen; Lockwood, William W; Robinson, Wendy P; Jurisica, Igor; Lam, Wan L.
Afiliação
  • Becker-Santos DD; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada. dbecker@bccrc.ca.
  • Thu KL; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • English JC; Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • Pikor LA; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Martinez VD; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Zhang M; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Vucic EA; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Luk MT; Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • Carraro A; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Korbelik J; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Piga D; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Lhomme NM; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Tsay MJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Yee J; Department of Surgery, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • MacAulay CE; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Lam S; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Lockwood WW; Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Robinson WP; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Jurisica I; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Lam WL; Departments of Medical Biophysics and Computer Science, University of Toronto, Toronto, Ontario, Canada.
J Pathol ; 240(2): 161-72, 2016 10.
Article em En | MEDLINE | ID: mdl-27357447
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / MicroRNAs / Fatores de Transcrição NFI / Neoplasias Pulmonares / Invasividade Neoplásica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / MicroRNAs / Fatores de Transcrição NFI / Neoplasias Pulmonares / Invasividade Neoplásica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article